How it works: Activates GLP-1 receptors in the body Year FDA approved (for weight loss): 2014 How taken: Once-a-day injection Average weight loss: 8% of body weight Common side effects: Nausea, vomiting, diarrhea, constipation, increased heart rate, dizziness, mood changes, fatigue, low blood glucose How it works: Activates GLP-1 receptors in the body Year FDA approved (for weight loss): 2021 How taken: Once-a-week injection or daily as a pill Average weight loss: 15% of body weight Common side effects: Nausea, vomiting, diarrhea, constipation, abdominal (belly) pain, headache, heartburn or reflux, dizziness, mood changes, fatigue, low blood glucose How it works: Activates GLP-1 and GIP receptors in the body Year FDA approved (for weight loss): 2022 How taken: Once-a-week injection Average weight loss: 20% of body weight Common side effects: Nausea, vomiting, diarrhea, constipation, abdominal (belly) pain, heartburn or reflux, dizziness, mood changes, fatigue, low blood glucose, redness at injection site, allergic reactions How it works: Activates GLP-1 receptors in the body Year FDA approved (for weight loss): 2026 How taken: Daily as a pill Average weight loss: 11% of body weight Common side effects: Nausea, vomiting, diarrhea, constipation, abdominal (belly) pain, headache, heartburn or reflux, gas, hair loss, low blood glucose Weight-loss results can vary based on the type and dosage of GLP-1 drug used

If you notice any side effects, report them to our office immediately so we can adjust your treatment plan
To me, that is our only path forward right now is to figure out how to cover [the compounds], Cloud said
While excess subcutaneous fat can still affect health, it is generally considered less harmful than visceral fat
All these findings together might suggest that LC supplementation protect muscle from atrophy, especially in pathophysiological conditions
Pyrimethamine continues to be used, particularly in sub-Saharan Africa, for intermittent preventive treatment during pregnancy, where it helps reduce the risk of low birth weight associated with malaria [810], but also for seasonal malaria chemoprevention among children [11]